Arrowhead Pharmaceuticals Inc. logo

Arrowhead Pharmaceuticals Inc. (ARWR)

Market Closed
23 Feb, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
63. 14
-0.45
-0.71%
$
8.9B Market Cap
- P/E Ratio
- Div Yield
1,734,267 Volume
-1.55 Eps
$ 63.59
Previous Close
Day Range
62.39 64.2
Year Range
9.57 76.76
Want to track ARWR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
ARWR earnings report is expected in 76 days (11 May 2026)
Name Time Cons. EPS Eps
Arrowhead Pharmaceuticals Inc. logo
ARWR Arrowhead Pharmaceuticals Inc.
11 May 2026 (In 2 months)
-
-
Arrowhead Pharmaceuticals Inc. logo
ARWR Arrowhead Pharmaceuticals Inc.
10 Feb 2026
0.11
0.22
Arrowhead Pharmaceuticals Inc. logo
ARWR Arrowhead Pharmaceuticals Inc.
9 Feb 2026
0.82
-
Arrowhead Pharmaceuticals Inc. logo
ARWR Arrowhead Pharmaceuticals Inc.
5 Feb 2026
0.6
-
Arrowhead Pharmaceuticals Inc. logo
ARWR Arrowhead Pharmaceuticals Inc.
1 Dec 2025
-
-
Arrowhead Pharmaceuticals Inc. logo
ARWR Arrowhead Pharmaceuticals Inc.
25 Nov 2025
0.13
-
Arrowhead Pharmaceuticals Inc. logo
ARWR Arrowhead Pharmaceuticals Inc.
11 Aug 2025
-
-
Arrowhead Pharmaceuticals Inc. logo
ARWR Arrowhead Pharmaceuticals Inc.
7 May 2025
-
2.75
Arrowhead Pharmaceuticals Inc. logo
ARWR Arrowhead Pharmaceuticals Inc.
4 Feb 2025
-
-
Arrowhead Pharmaceuticals Inc. logo
ARWR Arrowhead Pharmaceuticals Inc.
27 Nov 2024
-
-
Arrowhead Pharmaceuticals Inc. logo
ARWR Arrowhead Pharmaceuticals Inc.
5 Aug 2024
-
-
Arrowhead Pharmaceuticals Inc. logo
ARWR Arrowhead Pharmaceuticals Inc.
12 Jun 2024
-
-
Arrowhead Pharmaceuticals Inc. logo
ARWR Arrowhead Pharmaceuticals Inc.
30 Apr 2024
-
-
Arrowhead Pharmaceuticals Inc. logo
ARWR Arrowhead Pharmaceuticals Inc.
5 Feb 2024
-
-
Arrowhead Pharmaceuticals Inc. logo
ARWR Arrowhead Pharmaceuticals Inc.
29 Nov 2023
-
-
Arrowhead Pharmaceuticals Inc. logo
ARWR Arrowhead Pharmaceuticals Inc.
14 Dec 2016
-
-
Arrowhead Pharmaceuticals Inc. logo
ARWR Arrowhead Pharmaceuticals Inc.
9 Aug 2016
-
-
Arrowhead Pharmaceuticals Inc. logo
ARWR Arrowhead Pharmaceuticals Inc.
10 May 2016
-
-
Arrowhead Pharmaceuticals Inc. logo
ARWR Arrowhead Pharmaceuticals Inc.
9 Feb 2016
-
-
Arrowhead Pharmaceuticals Inc. logo
ARWR Arrowhead Pharmaceuticals Inc.
14 Dec 2015
-
-
Arrowhead Pharmaceuticals Inc. logo
ARWR Arrowhead Pharmaceuticals Inc.
4 Aug 2015
-
-
Arrowhead Pharmaceuticals Inc. logo
ARWR Arrowhead Pharmaceuticals Inc.
11 May 2015
-
-
Arrowhead Pharmaceuticals Inc. logo
ARWR Arrowhead Pharmaceuticals Inc.
9 Feb 2015
-
-
Arrowhead Pharmaceuticals Inc. logo
ARWR Arrowhead Pharmaceuticals Inc.
25 Nov 2014
-
-
Arrowhead Pharmaceuticals Inc. logo
ARWR Arrowhead Pharmaceuticals Inc.
12 Aug 2014
-
-
Arrowhead Pharmaceuticals Inc. logo
ARWR Arrowhead Pharmaceuticals Inc.
6 May 2014
-
-
Arrowhead Pharmaceuticals Inc. logo
ARWR Arrowhead Pharmaceuticals Inc.
4 Feb 2014
-
-
Arrowhead Pharmaceuticals Inc. logo
ARWR Arrowhead Pharmaceuticals Inc.
18 Dec 2013
-
-
Arrowhead Pharmaceuticals Inc. logo
ARWR Arrowhead Pharmaceuticals Inc.
8 Aug 2013
-
-
Arrowhead Pharmaceuticals Inc. logo
ARWR Arrowhead Pharmaceuticals Inc.
10 May 2013
-
-
Arrowhead Pharmaceuticals Inc. logo
ARWR Arrowhead Pharmaceuticals Inc.
14 Feb 2013
-
-

ARWR Earnings Reports FAQ

What is the earnings per share (EPS) for ARWR?

The current EPS is -1.55.

What is the company's earnings growth rate?

Arrowhead Pharmaceuticals Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.

When is the next earnings release date?

The next earnings release is expected to be on 2026-05-11, based on the ARWR's typical earnings announcement schedule.

What were the most recent quarterly earnings?

The most recent quarterly earnings were 0.22 per share, reported on 2026-02-10. For dividend history, visit the ARWR Dividends page.

What is the price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio is 287.00, calculated based on the most recent stock price of $63.14.